Additional European Equity News
Ashmore (ASHM LN) - Q4 Trading Statement (USD): AuM 47.6bln (prev. 46.2bln Q/Q). (Newswires)
AstraZeneca (AZN LN) - AstraZeneca’s Baxdrostat met primary and secondary endpoints in a Phase 3 trial for hypertension, showing significant systolic blood pressure reductions at 2mg and 1mg doses. (Newswires)
British American Tobacco (BATS LN) - Micheal Dijanosic to step down as regional director. (Newswires)
DCC (DCC LN) - Divests Info Tech unit in UK and Ireland for GBP 100mln. (Newswires)
GSK (GSK LN) - Submits Arexvy for adults 18-49 air to FDA. Decision anticipated in H1'26. (Newswires)
Leonardo (LDO IM) - Co. may offer drone technology but does not plan to open a plant in Ukraine, according to CEO. (Newswires)
Lloyds Banking Group (LYG) - Lloyds Banking Group is in advanced talks to acquire digital wallet provider Curve for up to GBP 120mln, below Curve’s GBP 133mln Series C valuation in 2023, Sky News reports. The deal would deepen Lloyds’ digital payments infrastructure amid regulatory pressure on Apple Pay (AAPL).
Partners Group (PGHN SW) - Co. is to sell a majority stake in Techem in a deal which values the Co. at EUR 6.7bln, including debt, according to Bloomberg.
Renk (R3NK GY) upgraded to Buy from Hold at Kepler
14 Jul 2025 - 07:20- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts